Substantially less is known, recognized or studied, regarding arterial or venous thrombosis in critically ill children. This lack of consensus regarding the clinical approach to thrombotic risk in children is further complicated by the changing capacity to inhibit thrombin that occurs throughout infancy and childhood (3, 4) . Although the risk of thrombosis in children is certainly lower compared to adults, recent reviews suggest that the incidence of pediatric VTE is increasing (5) (6) (7) . Epidemiologic data from a Canadian registry reported an annual incidence of central venous catheter-related VTE of 3.5 per 10,000 hospital admissions in children aged 3 months to 7 yrs (8) . More recent data , from the United States and international registries, report pediatric VTE rates from 5 to 8 cases per 10,000 hospital admissions (9, 10) . The U.S. data suggest a bimodal age distribution, with the highest VTE rates occurring in infants younger than 1 yr of age and adolescents >15 yrs. The latest data (up to 2007) report even higher VTE rates of 28-58 cases per 10,000 pediatric hospital admissions (7, 11) . Arterial thrombosis in children commonly involves the extremities (with indwelling vascular devices), central nervous system, or heart. The prevalence of pediatric arterial thromboembolism is poorly understood, but one center reported 8.5 per 10,000 admissions (12) . The increase in pediatric thrombosis incidence is thought to be the result of increased awareness coupled with medical advancements that have improved clinical outcomes in children with diseases previously resulting in mortality. Nevertheless, it does raise important surveillance and recognition issues that most pediatric intensive care units (ICUs), including ours, have not adequately addressed.
In the critical care setting, the risk of thrombosis is generally increased due to acquired factors, such as immobility, with decreased blood flow, damage to blood vessel walls from trauma and/or catheter insertion, and a tendency toward hypercoagulability secondary to inflammatory conditions. In an effort to characterize the thrombotic risk of our patients in the pediatric critical care unit, a risk assessment tool was developed. This tool was based on current understanding of thrombotic risk factors in children. The primary aim of this study was to evaluate this new pediatric risk assessment tool. Specific outcomes included compliance with tool assessments, description of risk factors present, percent of patients whose total risk score changed over time, and performance of the tool in identifying patients with a symptomatic thrombus.
MATERIALS AND METHODS
This was a prospective, observational cohort study in infants and children who were admitted to our free-standing children's hospital's pediatric ICU (PICU) during a 6-month study period (January1, 2010-June 30, 2010). All children admitted consecutively to the PICU were enrolled in the study -without exclusion. The ICU is a 26-bed unit, composed of critically ill medical, surgical, and trauma patients. Cardiac patients are admitted to a separate 16-bed unit and were not evaluated in this study. This protocol was reviewed and approved by the Colorado Multiple Institutional Review Board and informed parent/patient consent was waived.
Since all facets of patient care are managed via the electronic medical record, a 12-point computer-based assessment tool was developed and the tool was uploaded into the nursing shift-assessment flow sheet (Fig. 1) . One-onone training was completed with all nurses before implementation. This occurred over a span of 3 months. In addition, a PowerPoint overview of the risk assessment screening was presented in staff meetings. Training focused on a review of screening elements and the incorporation of the tool in the electronic medical record. Educational flyers on the screening tool were available in all bedside reference guides for the nurses. Since the majority of risk factors in the screening tool were readily attainable by history at admission or obvious based on condition (i.e., presence of central catheter), variability in assessment was not felt to be an issue and inter-rater reliability testing of the tool was not done.
Nurses were prompted to answer "yes" or "no" to 12 risk factors. We used thrombosis risk factors identified from earlier work as a basis for the checklist assessment tool (8, 9, (13) (14) (15) (16) (17) (18) (19) (20) (21) . The following risk factors were chosen: presence of a central venous catheter; immobility for >72 hrs; infection (defined as bacteremia, meningitis, pneumonia, or suspected infection with hemodynamic compromise); orthopedic surgery (knee, hip, and spine); major trauma (Injury Severity Score above 15); malignancy; oral contraceptive use (exogenous estrogen); burns >30% body surface area; acquired or inherited thrombophilia; age <1 yr old OR older than 14 yrs; obesity (defined as a body mass index above 30 or above 99 th percentile for weight); and hypercoagulable state (e.g., disseminated intravascular coagulation, lupus, diabetic ketoacidosis, nephrotic syndrome, hemolytic uremic syndrome). Thrombophilia is admittedly a broad term that can include several conditions in which there is an increased tendency toward excessive clotting. In our study, we screened for preexisting and acquired thrombophilia, such as protein C and S deficiency, factor V Leiden mutation, and antiphospholipid antibody syndrome. We did not perform any routine laboratory screening; rather, nurses inquired the family for the presence of preexisting conditions and when conditions were diagnosed (by hematology service) during the PICU stay. Each risk factor was allocated a single point and the computer calculated the summative risk score for each patient. At admission, nurses were asked to complete the electronic thrombosis risk assessment screening tool as part of their admission process. Since some risk factors are dynamic in nature and may change during a child's ICU stay (e.g., central catheter, infection, immobility), registered nurses were asked to do a daily risk assessment, in addition to the initial admission assessment. Treating physicians were blinded to the assessment scores. The primary aim of this study was to describe nursing compliance with the new thrombosis risk tool as defined by percent of admissions with a thrombosis score charted within 12 hrs of ICU arrival. Secondary aims of this study were to generate an estimate of risk factors present in our population and explore relationships between risk factors and confirmed thrombus.
Since some children were admitted to the ICU on more than one occasion during the study period, we elected to present risk factor distribution data based on admissions. Total score distribution is expressed as frequency and percent. The percent of admissions with a change in score during ICU stay was analyzed. To determine the predictive performance of total risk score and individual risk factors in identifying patients with confirmed thrombus (DVT, and pulmonary embolism, or arterial thrombus -excluding stroke), we used the highest individual score documented per patient before the identification of a clot. International Classification of Disease, Ninth Revision, Clinical Manifestations (ICD-9-CM) Figure 1 . Snapshot of the risk assessment tool as it appears in the electronic medical record. Bedside nurses document presence of risk factor by answering yes/no to risk. A total score is automatically generated by adding up all "yes" answers. Each assessment is electronically time and date stamped. PICU, pediatric intensive care unit; PO, oral; BCP, birth control pill; BSA, burn surface area; BMI, body mass index; VTE, venous thromboembolism; SLE, systemic lupus erythematosus; DKA, diabetic ketoacidosis; SSHb, homozygous for sickle cell hemoglobin.
codes identified charts of patients with a confirmed venous or arterial thrombus. The ICD-9-CM codes used were 415.1, 453.2, 453.4, 453.5, 453.6, 453.7, 453.8, 453.9, 444, 434, and. 325. We excluded superficial thrombophlebitis (ICD-9-CM 451.xx) because we were only interested in clinically significant deep thrombi. We then reviewed these charts for vascular ultrasounds, venograms, and spiral computed tomography scans to confirm all diagnoses. We described patients based on thrombus acquisition (in hospital vs. prehospital), vascular type (venous vs. arterial), vascular distribution (upper or lower extremity), and organ system affected (cerebral sinus thrombi or pulmonary embolus). To evaluate nonpharmacologic strategies for VTE prophylaxis, we recorded all patients with documentation of intermittent compression devices or compression stockings.
Statistical Analyses
Descriptive statistics (mean ± sd, or percent, as appropriate) were used to characterize study subjects, presence of individual thrombosis risk factors, and subjects with changes in risk scores. Incidence rates of all thrombi ( in-hospital and prehospital) were calculated on a per-admission basis. Cross-tabulation was used to display the risk of thrombosis by total risk score value (0, 1, 2, etc), and Pearson's chi-square test was used to test for association between occurrence of thrombosis and total risk score, and for association between occurrence of thrombosis and each of the 12 individual risk factors/items. Logistic regression analysis was performed to assess the predictive ability of total risk score (and in separate models, the predictive ability of the 12 individual risk factors/items) on the risk of prehospital and in-hospital thrombi. Adjusted risks are reported along with 95% confidence intervals. The −2 Log likelihood test and Nagelkerke's R-squared were used to assess the fit of the logistic regression models to the data. All tests were two sided, with the a priori level of significance (α) set at 0.05. Analyses were performed using SPSS version 18.0 (Chicago, IL).
RESULTS
A total of 800 admissions, representing 742 patients, were reviewed during the 6-month study period. Thrombosis risk scores were recorded for 707 admissions (45% female), which translates to a compliance rate of 88%. Mean age and weight of those children with a recorded score was 6.95 ± 6 yrs (range: 0.08-32 yrs) and 28 ± 23 kg (range: 3-148 kg), respectively. Most admissions (74%) were assigned a risk score that did not change during their PICU stay. Twenty-five percent of admissions had two to four changes in their risk score, while 1% of admissions had five or more changes in their risk scores recorded during their PICU stay. In those admissions with a change in score, 80% demonstrated an increase in score (mean increase of +1.23) and 20% demonstrated a decrease in score (mean decrease of −1.5). Overall, the most common change in score was +1 (in 76% of Figure 2 . Distribution of thrombosis risk factors identified in 707 admissions to the pediatric intensive care unit during a 6-month study period. n = raw number of admissions with each risk factor. DKA, diabetic ketoacidosis; SLE, systemic lupus erythematosus.
the increases) and −1 (in 67% of the decreases). Distribution of thrombosis risk factors observed in this study population is shown in Figure 2 . The most common risk factor documented was the presence of a central catheter, followed by infection. Thrombosis risk scores varied from 0 to 6 and are reported in Table 1 .
A total of 32 thrombi (18 in-hospital and 14 prehospital) were present in the study group. This translated to an overall occurrence rate of 4.3% (32 of 742), or 2.4% for in-hospital thrombi only (18 of 742) and 1.9% for prehospital thrombi only (14 of 742). Eighty-nine percent of in-hospital thrombi were classified as catheter related. The majority of thrombi were located in the venous system (n = 29), with three identified in the arterial system. All arterial thrombi were catheter-related and considered in-hospital thrombi. Fourteen thrombi were located in a lower extremity, 12 in an upper extremity, four in the pulmonary system, and two in the cerebral sinus system. Ten patients (1.4%) had documented use of nonpharmacologic strategies for thrombus prophylaxis. In the group of children with a symptomatic in-hospital thrombus (n = 18), only one child received any form of pharmacologic prophylaxis (aspirin and heparin).
Logistic regression analysis identified that for every 1-point increase in total thrombosis score, the risk of developing a symptomatic thrombus increased by 1.57-fold (95% confidence interval 0.132-5.49) to 2.12-fold (95% confidence interval 0.175-18.34) for prehospital and in-hospital thrombi, respectively (p < .05). The unique contribution of each individual risk factor, while adjusting for the contribution of other risks, was also calculated. The most predictive risk factors identified for development of any thrombus (combined pre and in-hospital) were thrombophilia (acquired or inherited) (p < .001), presence of a central catheter (p = .01), and age <1 or >14 yrs (p = .052). Of the 32 thrombi identified in this study, 23 were observed in children <1 or >14 yrs of age, with 78% in the later group. Risk factors most predicative of prehospital thrombus included age <1 or >14 yrs (p = .014), obesity (p = .013), trauma (p = .045), and thrombophilia (p = .003). Only thrombophilia was independently significant for predicting an in-hospital thrombus (p = .006). Six children with a symptomatic thrombus had thrombophilia identified as a risk. Half of these thrombi occurred before admission. Discrete conditions identified in these children included: May-Thurner Syndrome, Protein C and S deficiency, refractory/relapsing acute lymphoblastic leukemia, antiphospholipid antibody syndrome, congenital factor H deficiency, and hemophilia with hypofibrinogenemia. In the children who did not have a symptomatic thrombus (n = 710), five had thrombophilia identified as a risk. These included: congenital thrombocytopenia, antiphospholipid antibody syndrome, rattlesnake envenomation, pancytopenia with Moyamoya disease, and antibodies to prothrombin and platelets.
While the presence of one isolated risk factor did not seem to place a child at increased risk of symptomatic in-hospital thrombus, the presence of additional risk factors did (Fig. 3) . Three risk factor categories (exogenous estrogen use, burns >30% body surface area, and major orthopedic surgery) could not be assessed for their predictive performance because they did not vary across all three patient categories. Specifically, 100% of the patients exposed to estrogen and 100% of the patients with >30% burns had evidence of a thrombus at admission whereas 100% of the patients who underwent a major orthopedic surgery did not have evidence of any thrombus. Therefore, the logistic regression models could not mathematically discriminate between groups because there was no variability. Additionally, the importance of other factors may have been diminished because of interaction or colinearity effects. Therefore, chi-square analysis was performed on each individual risk factor and the results of this analysis are illustrated in Figure 4 .
DISCUSSION
In this prospective observational study, we demonstrated that a thrombosis scoring system, using a computer-based risk factor assessment tool, can be successfully incorporated into the nursing admission and shift-assessment workflow. Compliance with this tool was high at 88% and suggests that bedside nursing assessments can play an integral part in identifying children at risk for thrombosis. While the development of a thrombus in hospitalized children is uncommon, current rates may underestimate the true incidence due to the low suspicion in this population. The overall rate of thrombosis in our study was 4.3% (1.9% for prehospital and 2.4% for in-hospital). We expect that the true occurrence rate is higher because we reported only symptomatic thrombi and many thrombi remain silent.
To date, there is no consensus regarding thromboprophylaxis screening and prevention in hospitalized children. Previous prospective work in children (n = 59, age 10 ± 5.6 yrs) hospitalized for longer than 72 hrs attempted to define the incidence of DVT (22) . Unlike our study, which focused only on critically ill children, this study enrolled all children admitted to a pediatric unit during a 9-month period. After enrollment, patients underwent a weekly duplex scan to identify the presence of a DVT. Only one patient had a positive scan. These investigators concluded that the incidence of DVT was too rare to support routine screening and prevention strategies. More recent work, however, has determined that the diagnosis of DVT in children has significantly increased and that teenagers and children with underlying disorders are at the highest risk (16) . Additional evidence to support a dramatic increase in VTE among hospitalized children has been published and revealed a positive correlation between the annual number of admissions and the rate of VTE (7) . Once again, the data demonstrated that teenagers accounted for the majority of cases. In the current study, the strongest independent predictor of symptomatic thrombus development, for both in-hospital and prehospital acquisition, was the presence of thrombophilia. Additional important factors, identified with logistic regression and chi-square analyses, included exposure to exogenous estrogen, obesity, presence of a central catheter, infection, and age <1 yr or >14 yrs. In our study, all patients with an in-hospital thrombus had a central catheter during their PICU admission. Eighty-nine percent of these patients had a catheter-associated thrombus (n = 16 of 18; three arterial and 13 venous). The remaining two patients had thrombi that occurred at contralateral sites to the catheter-insertion site (catheter in right upper arm with thrombus in left iliac vein extending through common femoral vein and catheter in right vena cava with thrombus in left basilic vein just proximal to the antecubital fossa) and were thus not classified as catheter associated.
We are not the first group to use a scoring system to identify patients at risk of thrombus development. Previous work in children with acute lymphoblastic leukemia, investigated a scoring system to identify those at risk for VTE during induction chemotherapy (23) . This scoring system differed from our 12-point scoring system in two ways. First, they used type of chemotherapy regimen, presence of a central catheter, and known genetic thrombophilic abnormalities as the only risks (total score could vary from 0 to 3). Second, their system did not treat all risks the same -some risks were weighted higher than others. These investigators found that a total score above 2.5 was predictive of a symptomatic VTE. , acquisition of thrombus in-hospital (white bars, denominator = 18) and no evidence of thrombus (hatched box, denominator = 637). Raw numbers of patients with specific risk are expressed above each set of bars. Chi-square analysis identified significant differences between groups for the following risk factors: age <1 or >14 yrs (p = .001); exogenous estrogen (p < .001); obesity (p < .001); central catheter (p < .001); infection (p < .001); thrombophilia (p < .001). DKA, diabetic ketoacidosis; SLE, systemic lupus erythematosus; BSA, body surface area.
